iPSC reprogramming considerations for translational research

An overview of practical considerations for generating iPSCs that can be effectively transitioned toward clinical trials.

This 30 minute on-demand webinar reviews the challenges in reprogramming, balancing safety and efficiency, and optimizing iPSC culture systems for clinical applications. This webinar discusses some of the key crossroads and challenges that researchers face when choosing a method for iPSC generation, as well as provide perspective to find a balance between safety, efficacy, definition, and clinical compatibility in both reprogramming technologies and iPSC culture systems.

This webinar is for those who are:

• Researchers working with pluripotent stem cells
• Researchers new to reprogramming and iPSC culture
• Labs working in the field of regenerative medicine
• Stem cell core facilities
• Cell therapy organizations

This webinar was originally written and presented by Lia Kent, Captivate Bio Director of Technology (previously of Biological Industries USA), and produced as a Featured Spotlight webinar by RegMedNet in 2017. The original webinar is currently available on regmednet.com. Image: Giovanni Cancemi/Shutterstock.

Lia Kent began her career with human pluripotent stem cells in 2003 at WiCell Research Institute and in the lab of Dr. James Thomson at the University of Wisconsin-Madison. For the several years, she has been providing technical support and hands-on training for scientists across the world on a variety of methods, including human pluripotent stem cell culture techniques, cutting-edge reprogramming technologies, and best practices in cell culture laboratory maintenance and sterility.